Related Experiment Videos
A clinical assessment of MedisGroups
1Evans Memorial Department of Clinical Research and Medicine, Boston University Medical Center, MA.
Abstract:
Interest has focused recently on measuring severity of illness, both to improve the fairness of diagnosis related group-based reimbursement and to facilitate judgments about hospital quality of care. MedisGroups is a prominent, proprietary severity-measurement system, recently mandated for use by all Pennsylvania hospitals. We reviewed MedisGroups and its key clinical findings. MedisGroups produces admission scores, from 0 through 4, indicating increasing risk of imminent organ failure. Score computation is independent of diagnosis, but many key clinical findings are disease specific and require particular diagnostic technologies. Using a database including patients 65 years of age and older from 24 hospitals, we found that fewer than 1% of patients with scores of 0 or 1 died in-hospital, compared with 60% of those with scores of 4. Questions remain about the impact of the procedural nature of many key clinical findings and the independence from diagnosis. Further study is needed to determine the utility of MedisGroups for policy purposes.
Insights
The MedisGroups severity-of-illness scoring system shows a strong correlation between higher scores and in-hospital mortality. This system, mandated for Pennsylvania hospitals, requires further study for policy utility.
Area of Science:
- Health Services Research
- Medical Informatics
Background:
- Measuring illness severity is crucial for fair reimbursement and assessing hospital quality.
- MedisGroups is a proprietary severity-measurement system mandated for all Pennsylvania hospitals.
Purpose of the Study:
- To review the MedisGroups system and its clinical findings.
- To evaluate the utility of MedisGroups for policy purposes.
Main Methods:
- Review of the MedisGroups system and its scoring mechanism.
- Analysis of a database of patients aged 65+ from 24 hospitals.
Main Results:
- MedisGroups assigns admission scores (0-4) indicating risk of organ failure, independent of diagnosis.
- In-hospital mortality was <1% for scores 0-1 versus 60% for score 4.
- Key clinical findings are often disease-specific and technology-dependent.
Conclusions:
- MedisGroups demonstrates a clear link between severity scores and patient outcomes.
- Further research is needed to address concerns about procedural findings and diagnostic independence for policy applications.